Switch theme
Sign up to access all valuation multiples
FluoGuide AS is a clinical-stage biotechnology company focused on developing drugs that maximize surgical outcomes by making cancer fluorescent. Its technology includes uPAR, which is part of a proteolytic system, and FG001, a product injected into the patient's vein prior to surgery.
2018
8
LTM Revenue n/a
LTM EBITDA -$8.1M
$50.0M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
FluoGuide has a last 12-month revenue of n/a and a last 12-month EBITDA of -$8.1M.
In the most recent fiscal year, FluoGuide achieved revenue of n/a and an EBITDA of -$3.4M.
FluoGuide expects next 12-month revenue of XXX and NTM EBITDA of XXX
See FluoGuide valuation multiples based on analyst estimates| FY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
|---|---|---|---|---|---|
| Revenue | n/a | n/a | XXX | XXX | XXX |
| Gross Profit | n/a | n/a | XXX | XXX | XXX |
| Gross Margin | NaN% | NaN% | XXX | XXX | XXX |
| EBITDA | -$4.3M | -$3.4M | XXX | XXX | XXX |
| EBITDA Margin | -Infinity% | -Infinity% | XXX | XXX | XXX |
| Net Profit | -$2.7M | -$3.8M | XXX | XXX | XXX |
| Net Margin | -Infinity% | -Infinity% | XXX | XXX | XXX |
| Net Debt | n/a | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 15, 2025, FluoGuide's stock price is SEK 39 (or $4).
FluoGuide has current market cap of SEK 530M (or $52.6M), and EV of SEK 503M (or $50.0M).
See FluoGuide trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $50.0M | $52.6M | XXX | XXX | XXX | XXX | $-0.38 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 15, 2025, FluoGuide has market cap of $52.6M and EV of $50.0M.
FluoGuide's trades at n/a LTM EV/Revenue multiple, and -8.9x LTM EBITDA.
Analysts estimate FluoGuide's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for FluoGuide and 10K+ public comps| FY 2024 | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|
| EV | $50.0M | XXX | XXX | XXX |
| EV/Revenue | n/a | XXX | XXX | XXX |
| EV/EBITDA | -14.8x | XXX | XXX | XXX |
| P/E | -18.3x | XXX | XXX | XXX |
| P/E/Growth | n/a | XXX | XXX | XXX |
| EV/FCF | -16.8x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpFluoGuide's NTM/LTM revenue growth is n/a
FluoGuide's revenue per employee for the last fiscal year averaged n/a, while opex per employee averaged $0.4M for the same period.
Over next 12 months, FluoGuide's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate FluoGuide's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for FluoGuide and other 10K+ public comps| FY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|---|
| Revenue Growth | n/a | XXX | XXX | XXX | XXX |
| EBITDA Margin | n/a | XXX | XXX | XXX | XXX |
| EBITDA Growth | -22% | XXX | XXX | XXX | XXX |
| Rule of 40 (SaaS-only) | n/a | XXX | XXX | XXX | XXX |
| Revenue per Employee | n/a | XXX | XXX | XXX | XXX |
| Opex per Employee | $0.4M | XXX | XXX | XXX | XXX |
| S&M Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| G&A Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| R&D Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| Opex to Revenue | n/a | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Philips | XXX | XXX | XXX | XXX | XXX | XXX |
| Perspective Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| SmartVest | XXX | XXX | XXX | XXX | XXX | XXX |
| InfuSystem | XXX | XXX | XXX | XXX | XXX | XXX |
| Myomo | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
FluoGuide acquired XXX companies to date.
Last acquisition by FluoGuide was XXXXXXXX, XXXXX XXXXX XXXXXX . FluoGuide acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign Up| When was FluoGuide founded? | FluoGuide was founded in 2018. |
| Where is FluoGuide headquartered? | FluoGuide is headquartered in Sweden. |
| How many employees does FluoGuide have? | As of today, FluoGuide has 8 employees. |
| Is FluoGuide publicy listed? | Yes, FluoGuide is a public company listed on STO. |
| What is the stock symbol of FluoGuide? | FluoGuide trades under FLUO ticker. |
| When did FluoGuide go public? | FluoGuide went public in 2019. |
| Who are competitors of FluoGuide? | Similar companies to FluoGuide include e.g. Philips, Perspective Therapeutics, SmartVest, InfuSystem. |
| What is the current market cap of FluoGuide? | FluoGuide's current market cap is $52.6M |
| What is the current EBITDA of FluoGuide? | FluoGuide's last 12-month EBITDA is -$8.1M. |
| What is the current EV/EBITDA multiple of FluoGuide? | Current EBITDA multiple of FluoGuide is -8.9x. |
| Is FluoGuide profitable? | Yes, FluoGuide is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
